MB "Drugelių namai" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
16,268 |
- |
3,419 |
3,248 |
- |
0.22 |
1.24 |
23.12 |
19.97 |
3,656 |
4,542 |
0 |
8,198 |
2022 |
---|
9,468 |
- |
806 |
766 |
- |
0.47 |
0.65 |
10.05 |
8.09 |
4,422 |
2,896 |
0 |
7,318 |
2023 |
---|
7,411 |
- |
1,698 |
1,613 |
- |
0.81 |
0.02 |
25.30 |
21.76 |
6,036 |
103 |
0 |
6,139 |
Register and
explore Okredo data2023 |
---|
7,411 |
- |
1,698 |
1,613 |
- |
0.81 |
0.02 |
25.30 |
21.76 |
6,036 |
103 |
0 |
6,139 |
Register and
explore Okredo data2023
Turnover (€)
7,411 €-22 % *
Sales per employee (€)
-Profit before tax (€)
1,698 €111 % *
Net Profit (€)
1,613 €111 % *
Profit per employee (€)
-Working capital requirement
0.81 72.34 % *
Debt-to-equity ratio
0.02 -96.92 % *
Total profitability (%)
25.30 %151.74 % *
Net profitability (%)
21.76 %168.97 % *
Equity (€)
6,036 €37 % *
Amounts Payable And Liabilities (€)
103 €-96 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
6,139 €-16 % *